Browse EX-10 agreements

**SCRIBE THERAPEUTICS INC. **

**NON-EMPLOYEE DIRECTOR COMPENSATION POLICY **

Each member of the Board of Directors (the “Board”) of Scribe Therapeutics Inc. (the “Company”) who is a non-employee director of the Company (each, a “Non-Employee Director”) will receive the compensation described in this Non-Employee Director Compensation Policy (this “Policy”) for such Non-Employee Director’s service on the Board. This Policy is effective as of the closing of the sale of shares of the Company’s common stock (the “Common Stock”) to the public pursuant to a registration statement declared effective by the U.S. Securities and Exchange Commission (the “IPO” and such date, the “Effective Date”). This Policy may be amended or terminated at any time in the sole discretion of the Board.

1.	**Cash Compensation **

…

**SCRIBE THERAPEUTICS INC. **

**2026 EQUITY INCENTIVE PLAN **

1. PURPOSE. The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to the success of the Company, and any Parents, Subsidiaries and Affiliates that exist now or in the future, by offering them an opportunity to participate in the Company’s future performance through the grant of Awards. Capitalized terms not defined elsewhere in the text are defined in Section*** 28* of this Plan.

2.	**SHARES SUBJECT TO THIS PLAN. **

…

**SCRIBE THERAPEUTICS, INC. **

**2026 EMPLOYEE STOCK PURCHASE PLAN **

1.  PURPOSE. The purpose of this Plan is to provide eligible employees of Scribe Therapeutics, Inc. (the “Company”) and the Participating Corporations with a means of acquiring an equity interest in the Company, to enhance such employees’ sense of participation in the affairs of the Company. Capitalized terms not defined elsewhere in the text are defined in Section 28 of this Plan.

…

**STOCK PURCHASE AGREEMENT **

This STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of July 17, 2026 (the “Effective Date”), by and between Aventis Inc., a Pennsylvania corporation (the “Investor”), and Scribe Therapeutics Inc., a Delaware corporation (the “Company”).

WHEREAS, the Company is proposing to issue and sell to the Investor (the “Offering”) the lesser of (i) $7,500,000 of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and (ii) Common Stock representing 4.99% of the outstanding Common Stock of the Company immediately following the Closing (as defined herein), contemporaneously with the Company’s initial public offering of Common Stock (“IPO”, pursuant to the terms and subject to the conditions set forth in this Agreement;

…

** **

Armata Pharmaceuticals, Inc.

5005 McConnell Ave

Los Angeles, California 90066

July 17, 2026

Dear David:

This letter agreement (this “Agreement”) is intended to confirm our mutual agreement with respect to your continued employment with Armata Pharmaceuticals, Inc. (the “Company”) from and after the date hereof.

1.               Position. You agree to serve as the Company’s Chief Financial Officer, reporting directly to the Chief Executive Officer of the Company. You agree to devote your full business time and attention to your work for the Company. Except upon the prior written consent of the Board of Directors of the Company (the “Board”), you will not, during your employment with the Company, (i) accept or maintain any other employment, or (ii) engage, directly or indirectly, in any other business activity (whether or not pursued for pecuniary advantage) that might interfere with your duties and responsibilities as a Company employee or create a conflict of interest with the Company.

…

amendment No. 1
TO
Employment agreement

This Amendment No. 1 (this “Amendment”) to the Employment Agreement (as defined below) is entered into as of July 17, 2026, by and between Armata Pharmaceuticals, Inc. (the “Company”) and Pierre Kyme (the “Employee”).

WHEREAS, the Company and the Employee are parties to that certain employment letter agreement, dated June 1, 2024 (the “Employment Agreement”), which governs the terms of the Employee’s employment with the Company; and

WHEREAS, the Company and the Employee now desire to amend the Employment Agreement.

NOW, THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:

…

Execution Version

THIRD AMENDED AND RESTATED CREDIT AGREEMENT

Dated as of July 19, 2026

among

MAGNOLIA OIL & GAS INTERMEDIATE LLC,
as Holdings

MAGNOLIA OIL & GAS OPERATING LLC
as the Borrower,

The Several Lenders
from Time to Time Parties Hereto,

CITIBANK, N.A.,
as Administrative Agent, Collateral Agent,
Swingline Lender, an Issuing Bank and a Lender,

and

CITIBANK, N.A., JPMORGAN CHASE BANK, N.A., WELLS FARGO BANK, N.A., BANK OF
AMERICA, N.A., CAPITAL ONE, NATIONAL ASSOCIATION,

KEYBANK NATIONAL ASSOCIATION,

MUFG BANK, LTD., PNC CAPITAL MARKETS LLC,

REGIONS BANK, THE BANK OF NOVA SCOTIA, HOUSTON BRANCH, TRUIST BANK, and
FIFTH THIRD BANK, N.A. AS SUCCESSOR BY MERGER TO COMERICA BANK, NATIONAL
ASSOCIATION
as Joint Lead Arrangers

CITIBANK, N.A., JPMORGAN CHASE BANK, N.A., and WELLS FARGO BANK, N.A.,

as Joint Bookrunners

TABLE OF CONTENTS

Page

ARTICLE 1
Definitions

…

Chief Executive Officer

EXHIBIT A

Change in Control and Severance Policy
Participation Agreement

This Participation Agreement (“Agreement”) is made and entered into by and between **Hali Borenstein **on the one hand, and Reformation Inc. (the “Company”) on the other.

You have been designated as eligible to participate in the Policy, a copy of which is attached hereto, under which you are eligible to receive the following severance payments and benefits upon a Qualified Termination, subject to the terms and conditions of the Policy.

For purposes of this Agreement under the Policy, a “Qualified Termination” means a termination of the Eligible Employee’s employment:

(i) either (A) by the Company other than for Cause, death, or Disability or (B) by you for Good Reason, in either case, during the Change in Control Period (a “COC Qualified Termination”) or

…

SECOND AMENDED AND RESTATED

STOCKHOLDERS AGREEMENT

OF REFORMATION INC.

Dated as of [****●], 2026

TABLE OF CONTENTS

Page

Section 1 EFFECTIVENESS; DEFINITIONS		1
Section 1.1	Effective Time	1

…

REFORMATION INC.

2026 OMNIBUS INCENTIVE PLAN

RESTRICTED STOCK UNIT AGREEMENT

GRANT NOTICE

This Grant Notice and Award Terms and Conditions (including any attachments hereto, as applicable) (collectively, this “Agreement”), dated as of the grant date set forth below (the “Grant Date”), is made by and between Reformation Inc., a Delaware corporation (the “Company”), and the employee named below (the “Participant”). Any capitalized term that is used but not defined in this Agreement shall have the meaning ascribed to such term in the Reformation Inc. 2026 Omnibus Incentive Plan, as may be amended and/or restated from time to time (the “Plan”).

…

REFORMATION INC.

2026 OMNIBUS INCENTIVE PLAN

PERFORMANCE STOCK UNIT AGREEMENT

GRANT NOTICE

This Grant Notice and Award Terms and Conditions (including any attachments hereto, as applicable) (collectively, this “Agreement”), dated as of the grant date set forth below (the “Grant Date”), is made by and between Reformation Inc., a Delaware corporation (the “Company”), and the employee named below (the “Participant”). Any capitalized term that is used but not defined in this Agreement shall have the meaning ascribed to such term in the Reformation Inc. 2026 Omnibus Incentive Plan, as may be amended and/or restated from time to time (the “Plan”).

…

July 17, 2026

Hali Borenstein
Sent via e-mail

Dear Ms. Borenstein,

This letter agreement (the “Agreement”) is entered into between Hali Borenstein (“you”) and, LYMI, Inc (d/b/a The Reformation) (the “Company” or “we”), effective upon the effectiveness of the registration statement relating to Reformation Inc.’s initial public offering (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement supersedes and replaces any and all employment terms, compensation, or benefits you may have had or to which you may have been entitled prior to the Effective Date.

…